Sunday 18 October 2026 Export RLMD’s income statement to Excel — free account

Relmada Therapeutics, Inc.

In the quarter to June 2026, EPS grew 63.3% and free cash flow fell 50.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

3.10 0.10 −3.13%

Follow RLMD

Alert me

Market cap: $341.3M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(196.79%)	(94.05%)	(48.83%)	(55.66%)
ROA Full definition →		(159.13%)	(82.08%)	(44.77%)	(51.57%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(581.23%)	(65.54%)	(26.47%)	(29.26%)
Average Days of Receivables Full definition →		—	—	—	0.00
Free Cash Flow per Share Full definition →		(1.20)	(1.16)	(0.49)	(0.41)
Free Cash Flow Full definition →		(39.99)	(45.79)	(42.79)	(45.99)
Other line items
Cash ROIC Full definition →		(171.25%)	(25.51%)	(9.45%)	(10.84%)
Accounts Receivable Turnover Full definition →		—	—	—	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.71	0.80	0.73	0.74
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(1.20)	(1.16)	(0.49)	(0.41)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly